Nuzenio

Leerink Partners Upgrades

Leerink Partners Upgrades news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 12 latest news signals 7 publisher sources 100/100 entity strength

Latest news

Leerink upgraded Halozyme to Outperform on growth, market leadership - TipRanksTipRanks · Fri, 07 Aug 2026 19:00:22 GMT Leerink Partners Adjusts Price Target on Waters to $450 From $420, Maintains Outperform Rating - finance.yahoo.comfinance.yahoo.com · Wed, 05 Aug 2026 11:36:53 GMT Snowflake To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Monday - webull.comwebull.com · Tue, 04 Aug 2026 14:35:50 GMT Leerink Partners Upgrades Replimune Group to Outperform From Market Perform, Adjusts Price Target to $17 From $11 - marketscreener.commarketscreener.com · Tue, 04 Aug 2026 12:08:07 GMT REPL Upgraded by Leerink Partners -- Price Target Raised to $17. - GuruFocusGuruFocus · Tue, 04 Aug 2026 11:25:18 GMT Leerink Partners Adjusts Price Target on Incyte to $155 From $131, Maintains Outperform Rating - finance.yahoo.comfinance.yahoo.com · Mon, 03 Aug 2026 13:04:26 GMT Leerink Partners Upgrades Humana to Outperform From Market Perform, Adjusts PT to $513 From $255 - marketscreener.commarketscreener.com · Thu, 30 Jul 2026 13:28:51 GMT JPMorgan Raises Price Target on Equinix to $1,300 From $1,200, Maintains Overweight Rating - finance.yahoo.comfinance.yahoo.com · Thu, 30 Jul 2026 07:00:00 GMT

Timeline

Fri, 07 Aug 2026 19:00:22 GMTLeerink upgraded Halozyme to Outperform on growth, market leadership - TipRanks

Wed, 05 Aug 2026 11:36:53 GMTLeerink Partners Adjusts Price Target on Waters to $450 From $420, Maintains Outperform Rating - finance.yahoo.com

Tue, 04 Aug 2026 14:35:50 GMTSnowflake To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Monday - webull.com

Tue, 04 Aug 2026 12:08:07 GMTLeerink Partners Upgrades Replimune Group to Outperform From Market Perform, Adjusts Price Target to $17 From $11 - marketscreener.com

Tue, 04 Aug 2026 11:25:18 GMTREPL Upgraded by Leerink Partners -- Price Target Raised to $17. - GuruFocus

Mon, 03 Aug 2026 13:04:26 GMTLeerink Partners Adjusts Price Target on Incyte to $155 From $131, Maintains Outperform Rating - finance.yahoo.com

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.

Connected entities

From12 live mentions Price Target8 live mentions Outperform From Market6 live mentions Perform6 live mentions Leerink Partners Adjusts4 live mentions Maintains Outperform Rating4 live mentions Equinix4 live mentions Maintains Overweight Rating4 live mentions Gossamer Bio4 live mentions Halozyme2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Leerink Partners Upgrades.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

7 distinct publisher/source names are currently connected to this entity page.